Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06428669 · ClinicalTrials.gov registry record · Phase 4
Effect of Nitropaste in Chest Masculinizing Surgery
A Phase 4 study of Gender Dysphoria, sponsored by University of Virginia.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 256
- Enrollment target
- 1
- Study location
NCT06428669 is a Phase 4 study of Gender Dysphoria that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 256 participants, above the 147-participant average among 8 other Gender Dysphoria trials with a reported enrollment target (74% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06428669, a Phase 4 study of Gender Dysphoria, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
Nitropaste is a topical agent that contains 2% nitroglycerin. It is an effective vascular smooth dilator, with more powerful effect on venous vasculature than arterial vasculature. While its main indication is for angina pectoris, there have been many studies showing improved survival of axial and random pattern flaps. Furthermore, recent clinical studies highlight significantly decreased mastectomy flap wound complication and need for sharp debridement. Nitropaste has low rates of side effects and is very well tolerated in general. To this date, there's no study that investigates its utility on patients who are undergoing chest masculinizing surgery. The purpose of this study is to investigate the potential utility of nitropaste in reducing rates of wound complications in patients undergoing chest masculinizing surgery.
Conditions Studied
Interventions
- DRUG Nitro-Bid 2 % Topical Ointment
Study Locations (1)
Virginia
- University of Virginia Medical Center - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2025-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06428669
The ClinicalTrials.gov registry entry for NCT06428669 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 147-participant average among 8 other Gender Dysphoria trials with a reported enrollment target (74% higher). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gender Dysphoria appearing as the primary indexed condition, and to 1 intervention - of which Nitro-Bid 2 % Topical Ointment is the first listed.
NCT06428669 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06428669 about?
NCT06428669 is a clinical study titled "Effect of Nitropaste in Chest Masculinizing Surgery". Nitropaste is a topical agent that contains 2% nitroglycerin. It is an effective vascular smooth dilator, with more powerful effect on venous vasculature than arterial vasculature. While its main indication is for angina pectoris, there have been many studies showing improved survival of axial and r...
What is the current status of trial NCT06428669?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 256 participants. The study started on 2022-08-15. Estimated completion is 2025-11.
What conditions does trial NCT06428669 study?
This clinical trial studies the following conditions: Gender Dysphoria.
What interventions are being tested in trial NCT06428669?
The interventions under investigation include: Nitro-Bid 2 % Topical Ointment (DRUG).
Who is sponsoring clinical trial NCT06428669?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06428669 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gender Dysphoria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
RECRUITING
-
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
RECRUITING · NA
-
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
RECRUITING · Phase 3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
ACTIVE NOT RECRUITING
-
Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.